“There are a lot of treatment options depending on how bad your liver disease is, how many cancers in the liver you have, how ...

Fatty liver disease, now termed MASLD, is increasingly prevalent, particularly among those with weight issues, diabetes, or ...

The liver is the largest internal organ of the human body. This vital organ is crucial for the processes of digestion, ...

Weight loss without diet changes, along with loss of appetite, can be initial warning signs of liver cancer. Your stomach ...

Fatty liver may seem harmless now, but it could silently progress to liver cancer. Know the signs, risks, and expert-backed ...

A meta-analysis of 24 studies, previously published in the journal Cancers, showed a significant reduction of 46% in hepatocellular carcinoma risk among statins users compared with nonusers.

Imagine a future where the global incident cases of liver cancer almost doubles, rising from 870 000 cases in 2022 to over ...

Patients with hepatocellular carcinoma (HCC) who are metabolic-associated fatty liver disease (MAFLD)-positive and MAFLD-negative have similar rates of overall survival (OS) and progression-free ...

Key Takeaways The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed ...